Quote | Eupraxia Pharmaceuticals (OTCMKTS:EPRXF)
Last: | $3.04 |
---|---|
Change Percent: | 100.0% |
Open: | $0 |
Close: | $3.04 |
High: | $0 |
Low: | $0 |
Volume: | 10 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Eupraxia Pharmaceuticals (OTCMKTS:EPRXF)
2024-04-01 17:17:38 ET More on Eupraxia Pharmaceuticals Historical earnings data for Eupraxia Pharmaceuticals Financial information for Eupraxia Pharmaceuticals Read the full article on Seeking Alpha For further details see: Eupraxia Pharmaceuticals&n...
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has closed i...
Message Board Posts | Eupraxia Pharmaceuticals (OTCMKTS:EPRXF)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Eupraxia Pharmaceuticals Company Name:
EPRXF Stock Symbol:
OTCMKTS Market:
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 15, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has closed i...
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 12, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company, today announced that it has priced i...
NOT FOR DISSEMINATION IN THE UNITED STATES OR THROUGH U.S. NEWSWIRE SERVICES VICTORIA, British Columbia, March 11, 2024 (GLOBE NEWSWIRE) -- Eupraxia Pharmaceuticals Inc. ("Eupraxia" or the "Company") (TSX: EPRX), a clinical-stage biotechnology company, today announced the launch of an ove...